EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Network Pharmacology and Experimental Verification: SanQi-DanShen Treats Coronary Heart Disease by Inhibiting the PI3K/AKT Signaling Pathway

Min Zhao, Liuxiang Feng, Wenhua Li

Drug Design, Development and Therapy · 2024

DOI: 10.2147/dddt.s480248 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2024. Verfasst von Min Zhao und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Lijiang University of Culture and Tourism, Lijiang, Yunnan, 674100, People's Republic of China. Hauptthemen laut MEDLINE: Network Pharmacology, Drugs, Chinese Herbal, Proto-Oncogene Proteins c-akt, Signal Transduction. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Network PharmacologyDrugs, Chinese HerbalProto-Oncogene Proteins c-aktSignal TransductionPhosphatidylinositol 3-KinasesCoronary DiseaseAnimalsRatsSalvia miltiorrhizaRats, Sprague-DawleyMaleMolecular Docking SimulationDisease Models, AnimalHumans

Stichwörter der Autor:innen

PI3K/AKT signaling pathwaySQDScardiac troponin Icoronary heart diseaseexperiment validation

Substanzen

Drugs, Chinese HerbalProto-Oncogene Proteins c-aktPhosphatidylinositol 3-Kinasesdan-shen root extract

Autor:innen und Institutionen

  • School of Medicine, Lijiang University of Culture and Tourism, Lijiang, Yunnan, 674100, People's Republic of China.
  • People's Hospital of Yulong Naxi Autonomous County of Lijiang City, Lijiang, Yunnan, 674112, People's Republic of China.
  • School of Medicine, Xizang Minzu University, Xianyang Shaanxi, 712082, People's Republic of China.

Zitieren

APA

Zhao, M., Feng, L., & Li, W. (2024). Network Pharmacology and Experimental Verification: SanQi-DanShen Treats Coronary Heart Disease by Inhibiting the PI3K/AKT Signaling Pathway. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s480248

Vancouver

Zhao M, Feng L, Li W. Network Pharmacology and Experimental Verification: SanQi-DanShen Treats Coronary Heart Disease by Inhibiting the PI3K/AKT Signaling Pathway. Drug Design, Development and Therapy. 2024. doi:10.2147/dddt.s480248

BibTeX
@article{Zhao2024,
  author = {Zhao, Min and Feng, Liuxiang and Li, Wenhua},
  title = {Network Pharmacology and Experimental Verification: SanQi-DanShen Treats Coronary Heart Disease by Inhibiting the PI3K/AKT Signaling Pathway},
  journal = {Drug Design, Development and Therapy},
  year = {2024},
  doi = {10.2147/dddt.s480248}
}
Kostenlos starten →